vs
Immunovant, Inc.（IMVT）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Immunovant, Inc.的1.7倍（$14.0M vs $8.4M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -899.0%，领先908.8%），Immunovant, Inc.同比增速更快（140.7% vs 10.4%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-59.8M）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
IMVT vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.7倍
$8.4M
营收增速更快
IMVT
高出130.4%
10.4%
净利率更高
RVSB
高出908.8%
-899.0%
自由现金流更多
RVSB
多$59.1M
$-59.8M
损益表 — Q4 FY2024 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $14.0M |
| 净利润 | $-75.3M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -896.2% | 12.4% |
| 净利率 | -899.0% | 9.8% |
| 营收同比 | 140.7% | 10.4% |
| 净利润同比 | -26.7% | 11.8% |
| 每股收益（稀释后） | $-0.50 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTRVSB
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $13.3M | ||
| Q1 25 | — | $12.9M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $12.2M | ||
| Q1 24 | $8.4M | $9.0M |
净利润IMVTRVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $966.0K | ||
| Q1 24 | $-75.3M | $-3.0M |
营业利润率IMVTRVSB
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 10.2% | ||
| Q2 25 | — | 11.7% | ||
| Q1 25 | — | 11.3% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 10.0% | ||
| Q1 24 | -896.2% | -47.5% |
净利率IMVTRVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | — | 8.1% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | — | 7.9% | ||
| Q1 24 | -899.0% | -34.7% |
每股收益（稀释后）IMVTRVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | $-0.50 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $164.2M |
| 总资产 | $666.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTRVSB
| Q4 25 | — | $28.6M | ||
| Q3 25 | — | $32.8M | ||
| Q2 25 | — | $34.2M | ||
| Q1 25 | — | $29.4M | ||
| Q4 24 | — | $25.3M | ||
| Q3 24 | — | $31.0M | ||
| Q2 24 | — | $27.8M | ||
| Q1 24 | $635.4M | $23.6M |
股东权益IMVTRVSB
| Q4 25 | — | $164.2M | ||
| Q3 25 | — | $163.5M | ||
| Q2 25 | — | $162.0M | ||
| Q1 25 | — | $160.0M | ||
| Q4 24 | — | $158.3M | ||
| Q3 24 | — | $160.8M | ||
| Q2 24 | — | $155.9M | ||
| Q1 24 | $617.8M | $155.6M |
总资产IMVTRVSB
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $666.4M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $-736.0K |
| 自由现金流率自由现金流/营收 | -714.4% | -5.2% |
| 资本支出强度资本支出/营收 | 1.8% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $20.4M |
8季度趋势，按日历期对齐
经营现金流IMVTRVSB
| Q4 25 | — | $-506.0K | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $-697.0K | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $764.0K | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | $-59.7M | $12.8M |
自由现金流IMVTRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | $-59.8M | $7.1M |
自由现金流率IMVTRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | -714.4% | 79.0% |
资本支出强度IMVTRVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | 1.8% | 62.0% |
现金转化率IMVTRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
